CVE-2026-94016
SourceCodester Drug Recommendation System add_symptom cross site scripting
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- High
- User interaction
- Passive
What an attacker can affect
- Confidentiality
- None
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
SourceCodester Drug Recommendation System add_symptom cross site scripting
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
- Record
CVE-2026-94016- CVSS 4.0
- 4.8 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P - CVSS 3.1
- 2.4 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R - CVSS 3.0
- 2.4 Low
CVSS:3.0/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R - CVSS 2.0
- 3.3
AV:N/AC:L/Au:M/C:N/I:P/A:N/E:POC/RL:ND/RC:UR - Weakness
- CWE-79, CWE-94
- Updated
- 2026-11-02
EUVDEUVD-2026-83739
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
- Record
EUVD-2026-83739- CVSS 4.0
- 4.8 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-j97g-6cp9-956m
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This...
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
- Record
GHSA-j97g-6cp9-956m- CVSS 4.0
- 1.9 Low
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 2.4 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
- Record
CVE-2026-94016- CVSS 4.0
- 1.9 Low
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 2.4 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N - CVSS 2.0
- 3.3 Low
AV:N/AC:L/Au:M/C:N/I:P/A:N - Weakness
- CWE-79, CWE-94
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-94016 is a medium vulnerability (CVSS 4.8) in Sourcecodester Drug Recommendation System, published September 20, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.37%, the 31st percentile. No source names a fixed version.